Trailhead Biosystems
Pre-clinicalHigh quality iPSC-derived human cells for drug discovery and cell-based therapies
Founded
2014
Focus
Cell TherapyRegenerative Medicine
About
High quality iPSC-derived human cells for drug discovery and cell-based therapies
Funding History
2Total raised: $17.5M
Series A$15MUndisclosedMar 15, 2023
Seed$2.5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2014
LocationCleveland, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile